Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN61147621
ISRCTN61147621
Completed
Not Applicable

CML IV - Chronic phase chronic myeloid leukaemia/CML 2000

Medical Research Council (MRC) (UK)0 sites800 target enrollmentOctober 25, 2000
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionseukaemiaCancerChronic myeloid leukaemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
eukaemia
Sponsor
Medical Research Council (MRC) (UK)
Enrollment
800
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2000
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Medical Research Council (MRC) (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. The interval from diagnosis to registration does not exceed 3 months (if received only hydroxyurea in these 3 months proceed to register, if alpha Interferon (IFN) has been given contact co\-ordinators)
  • •2\. They are aged 18\-60; they have newly diagnosed CML
  • •3\. They have acceptable criteria for chronic phase
  • •4\. They have given informed consent and are willing to be randomised, there is no contraindication to collection of blood or marrow progenitor cells before treatment is commenced
  • •5\. They are not pregnant

Exclusion Criteria

  • •Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
CML V - chronic phase Chronic Myeloid LeukaemiaeukaemiaCancerMyeloid leukaemia
ISRCTN68784584niversity of Oxford (UK)800
Completed
Not Applicable
The Observational Study of Chronic Myeloid Leukemia Patients in Chronic Phase with Resistance or Intolerance to Preceding TKI in Japa
JPRN-UMIN000003582The Japanese Society of Hematology110
Active, not recruiting
Phase 1
Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose-finding study
EUCTR2012-005629-65-GBniversity of Birmingham15
Not yet recruiting
Not Applicable
Chronic Myeloid LeukemiaHealth Condition 1: C921- Chronic myeloid leukemia, BCR/ABL-positive
CTRI/2021/08/035398DRREETIKA RAMANATHA
Active, not recruiting
Not Applicable
Kroonista lymfaattista leukemiaa (KLL) sairastavien potilaiden pneumokokki-vasta-aineiden säilyvyys ja muistisolujen toiminta konjugaattirokotteen jälkeen. - KLLmuistiKroonista lymfaattista leukemiaa sairastavia potilaita ja heille immunologisesti terveitä verrokkejaMedDRA version: 1Level: LLTClassification code 10009310Term: <Manually entered code. Term in E.1.1>
EUCTR2009-012099-29-FITampere University Hospital